
NeuroMetrix NURO
Geschäftsbericht 2024
hinzugefügt 31.03.2025
NeuroMetrix DSO 2011-2025 | NURO
DSO Jährlich NeuroMetrix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.8 | 36 | 21.2 | 14.3 | 16.5 | 19.2 | 24.6 | 22.4 | 22.4 | 37.1 | 38.4 | 27 | 27.3 | 31.9 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 42.8 | 14.3 | 27.2 |
DSO Vierteljährlich NeuroMetrix
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 33.4 | 44.5 | 41.2 | - | 51.6 | 36.5 | 32.4 | - | 29 | 26.3 | 19.7 | - | 24.2 | 15.8 | 13.7 | - | 15 | 22.4 | 13.3 | - | 13.1 | 11.6 | 20.2 | - | 26.9 | 26.3 | 19.7 | - | 27 | 22.2 | 18.9 | - | 19.9 | 25.5 | 31 | - | 34.4 | 55.3 | 47 | - | 37.1 | 39.4 | 33.3 | - | 27.1 | 30.7 | 31.2 | - | 29.3 | 23.4 | 32.4 | - | 32.4 | 32.3 | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 55.3 | 11.6 | 28.5 |
DSO anderer Aktien in der Medizinische Instrumente
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
BioLife Solutions
BLFS
|
37.9 | $ 24.46 | 0.29 % | $ 1.13 B | ||
|
Baxter International
BAX
|
204 | $ 19.49 | 1.75 % | $ 9.94 B | ||
|
Becton, Dickinson and Company
BDX
|
50.4 | $ 200.45 | -0.25 % | $ 57.7 B | ||
|
Luminex Corporation
LMNX
|
58.6 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
9.92 | - | -9.52 % | $ 20.6 M | ||
|
Ekso Bionics Holdings
EKSO
|
131 | $ 4.63 | -0.96 % | $ 93.3 M | ||
|
Antares Pharma, Inc.
ATRS
|
123 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
65.5 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
91.1 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
75.4 | - | -0.05 % | $ 10.3 B | ||
|
Harvard Bioscience
HBIO
|
53.3 | $ 0.72 | -2.54 % | $ 30.5 M | ||
|
Varian Medical Systems, Inc.
VAR
|
123 | - | -0.02 % | $ 16.3 B | ||
|
ICU Medical
ICUI
|
26.4 | $ 148.07 | -0.24 % | $ 3.61 B | ||
|
Alcon
ALC
|
71 | $ 79.31 | 0.63 % | $ 40.4 B | ||
|
iRhythm Technologies
IRTC
|
43.6 | $ 169.32 | 0.29 % | $ 5.28 B | ||
|
AtriCure
ATRC
|
44.3 | $ 41.4 | -2.3 % | $ 1.94 B | ||
|
Atrion Corporation
ATRI
|
0.0506 | - | - | $ 810 M | ||
|
electroCore
ECOR
|
12.7 | $ 4.81 | 1.16 % | $ 26.5 K | ||
|
AngioDynamics
ANGO
|
54 | $ 13.33 | 1.45 % | $ 545 M | ||
|
Repro Med Systems
KRMD
|
48.7 | $ 5.74 | -0.69 % | $ 262 M | ||
|
The Cooper Companies
COO
|
68.9 | $ 81.24 | -1.02 % | $ 16.2 B | ||
|
Glaukos Corporation
GKOS
|
44 | $ 111.63 | 2.51 % | $ 5.41 B | ||
|
LeMaitre Vascular
LMAT
|
43.2 | $ 84.18 | 0.21 % | $ 1.89 B | ||
|
Haemonetics Corporation
HAE
|
54.9 | $ 80.32 | -3.79 % | $ 4.04 B | ||
|
InfuSystem Holdings
INFU
|
53.6 | $ 9.1 | -1.41 % | $ 188 M | ||
|
Masimo Corporation
MASI
|
12.7 | $ 137.49 | -0.61 % | $ 7.33 B | ||
|
Isoray
ISR
|
173 | - | 0.03 % | $ 108 M | ||
|
Merit Medical Systems
MMSI
|
49.5 | $ 86.68 | -0.02 % | $ 5.05 B | ||
|
Intuitive Surgical
ISRG
|
51.5 | $ 554.9 | 2.32 % | $ 197 B | ||
|
OraSure Technologies
OSUR
|
62.8 | $ 2.5 | 0.4 % | $ 186 M | ||
|
Microbot Medical
MBOT
|
167 | $ 2.27 | -6.02 % | $ 23.2 M | ||
|
Milestone Scientific
MLSS
|
16.7 | $ 0.37 | -5.15 % | $ 29.5 M | ||
|
Nephros
NEPH
|
35.7 | $ 4.89 | -2.69 % | $ 50.8 M | ||
|
Envista Holdings Corporation
NVST
|
56 | $ 22.12 | 0.68 % | $ 3.81 B | ||
|
ResMed
RMD
|
60.7 | $ 252.68 | 0.13 % | $ 36.9 B | ||
|
Pro-Dex
PDEX
|
83.1 | $ 43.41 | 0.07 % | $ 143 M | ||
|
Pulse Biosciences
PLSE
|
15.9 | $ 14.4 | 1.12 % | $ 692 M | ||
|
STAAR Surgical Company
STAA
|
100 | $ 23.87 | -1.08 % | $ 1.17 B | ||
|
STERIS plc
STE
|
68.6 | $ 252.93 | 0.4 % | $ 24.9 B | ||
|
Predictive Oncology
POAI
|
115 | - | - | $ 32.4 M | ||
|
Stereotaxis
STXS
|
60.8 | $ 2.35 | -1.05 % | $ 190 M | ||
|
Repligen Corporation
RGEN
|
69.4 | $ 157.97 | 0.37 % | $ 8.8 M | ||
|
Utah Medical Products
UTMD
|
132 | $ 57.77 | -0.57 % | $ 210 M | ||
|
DENTSPLY SIRONA
XRAY
|
64.3 | $ 11.4 | -1.51 % | $ 2.32 B | ||
|
Retractable Technologies
RVP
|
102 | $ 0.82 | -0.96 % | $ 24.5 M | ||
|
Teleflex Incorporated
TFX
|
54.1 | $ 126.72 | 0.04 % | $ 5.94 B | ||
|
West Pharmaceutical Services
WST
|
67.1 | $ 268.99 | 0.54 % | $ 19.6 B |